Prenetics Global Ltd
PRENW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001876431
In the last 90 days, Prenetics Global Ltd insiders filed 2 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $43.7K in total; no superinvestor holds it.
Other share classesPRE
13F holders, Q4 2024
Institutional positions in Prenetics Global Ltd as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q3 2024
- Shares held
- 3.64M
- +1.12M (+44.5%) vs. Q3 2024
- Total value
- $31.6K
- +$615 (+2.0%) vs. Q3 2024
- New holders
- 2
- 0 more added
- Sold out
- 1
- 3 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRENW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $43.7K |
| Q1 2026 | 14 | $60.7K |
| Q4 2025 | 16 | $101.9K |
| Q3 2025 | 16 | $95.5K |
| Q2 2025 | 18 | $143.2K |
| Q1 2025 | 15 | $34.7K |
| Q4 2024 | 17 | $31.6K |
| Q3 2024 | 17 | $31.7K |
| Q2 2024 | 22 | $59.3K |
| Q1 2024 | 23 | $32.6K |
| Q4 2023 | 24 | $48.0K |
| Q3 2023 | 25 | $215.8K |
| Q2 2023 | 23 | $392.8K |
| Q1 2023 | 23 | $332.4K |
| Q4 2022 | 27 | $617.9K |
| Q3 2022 | 29 | $1.73M |
| Q2 2022 | 30 | $1.35M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Prenetics Global Ltd; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LMR Partners LLP | 1,303,861 | $10.2K | 0.00% | +1,303,861 | New |
| Aspex Management (HK) Ltd | 1,166,666 | $9.00K | 0.00% | 00.0% | Unchanged |
| Nine Masts Capital Ltd | – | $2.83K | 0.00% | – | – |
| Citadel Advisors LLC | 314,288 | $2.45K | 0.00% | −16,360−4.9% | Reduced |
| Calamos Advisors LLC | 200,000 | $1.56K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 195,830 | $1.53K | 0.00% | −23,426−10.7% | Reduced |
| Vestcor Inc | 66,666 | $1.00K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 104,515 | $815 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 82,647 | $645 | 0.00% | 00.0% | Unchanged |
| PEAK6 LLC | 66,666 | $520 | 0.00% | +66,666 | New |
| Maso Capital Partners Ltd | 49,015 | $382 | 0.00% | 00.0% | Unchanged |
| Rivernorth Capital Management, LLC | 32,770 | $256 | 0.00% | 00.0% | Unchanged |
| State of Wisconsin Investment Board | 20,000 | $160 | 0.00% | 00.0% | Unchanged |
| DuPont Capital Management Corp | 16,666 | $130 | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 15,293 | $119 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,562 | $37 | 0.00% | −22,433−83.1% | Reduced |
| Tower Research Capital LLC (TRC) | 339 | $3 | 0.00% | 00.0% | Unchanged |
| Sona Asset Management (US) LLC | 0 | $0 | 0.00% | −186,538−100.0% | Sold out |
| PEAK6 Investments LLC | – | – | – | – | Not filed |